Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33M
-
Number of holders
-
256
-
Total 13F shares, excl. options
-
27.1M
-
Shares change
-
+1.25M
-
Total reported value, excl. options
-
$2.62B
-
Value change
-
+$117M
-
Put/Call ratio
-
0.42
-
Number of buys
-
127
-
Number of sells
-
-135
-
Price
-
$96.79
Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q3 2022
311 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q3 2022.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 256 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.1M shares
of 33M outstanding shares and own 82.16% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.04M shares), WELLINGTON MANAGEMENT GROUP LLP (2.61M shares), JPMORGAN CHASE & CO (1.7M shares), RIVERBRIDGE PARTNERS LLC (1.63M shares), AMERIPRISE FINANCIAL INC (1.08M shares), Point72 Asset Management, L.P. (1.07M shares), MACKENZIE FINANCIAL CORP (1M shares), STATE STREET CORP (870K shares), Bellevue Group AG (599K shares), and Bank of New York Mellon Corp (597K shares).
This table shows the top 256 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.